Keyphrases
Cirrhosis
100%
Decompensated Cirrhosis
31%
Carvedilol
21%
Ascites
21%
Hepatic Venous Pressure Gradient
19%
Propranolol
18%
Portal Hypertension
18%
Liver Cirrhosis
15%
Bacterial Translocation
15%
Randomized Placebo-controlled Trial
15%
Rifaximin
14%
Chronic Hepatitis B
14%
Bleeding Esophageal Varices
14%
Denmark
14%
PleurX
13%
Beta-blockers
11%
Systemic Hemodynamics
11%
Healthy Individuals
10%
Refractory Ascites
10%
Inflammation
10%
National Cohort Study
9%
Oxygenation
9%
Large-volume Paracentesis
9%
Liver
9%
Inflammation Markers
9%
Non-alcoholic Fatty Liver Disease (NAFLD)
9%
Cardiac Output
9%
Cirrhotic Patients
8%
Rebleeding
8%
Minor Effect
8%
Bacterial DNA
8%
Hyperdynamic Circulation
7%
Portal Pressure
7%
Variceal Bleeding
7%
Bleeding
7%
Randomized Trial
7%
Insulin-like Growth Factor System
7%
Autoimmune Liver Disease
7%
Registry Study
7%
Steatotic Liver Disease
7%
Hospitalization
7%
Portal Pressure Measurement
7%
Specialized Units
7%
Adherence to Guidelines
7%
Glucose Disturbances
7%
Ischemic Heart Disease
7%
Soluble Urokinase Plasminogen Activator Receptor (suPAR)
7%
Tunneled Peritoneal Catheter
7%
Outcome Comparison
7%
Cause of Death
7%
Medicine and Dentistry
Liver Cirrhosis
87%
Ascites
25%
Decompensated Liver Cirrhosis
24%
Chronic Hepatitis B
21%
Bacterial Translocation
15%
Rifaximin
14%
Carvedilol
14%
Fatty Liver
14%
Nonalcoholic Fatty Liver
14%
Hemodynamic
13%
Beta Adrenergic Receptor Blocking Agent
13%
Esophageal Varices
12%
Venous Pressure
12%
Liver Disease
11%
Portal Venous Pressure
11%
Paracentesis
10%
Bleeding
10%
Population
9%
Heart Output
9%
Propranolol
8%
Placebo
8%
Cohort Analysis
8%
Bacterial DNA
8%
Portal Hypertension
7%
Spontaneous Bacterial Peritonitis
7%
Ischemic Heart Disease
7%
Autoimmune Liver Disease
7%
Non Invasive Measurement
7%
Chronic Liver Disease
7%
Prospective Cohort Study
7%
Rehabilitation Engineering
7%
Hospital Care
7%
Outpatient
7%
Urokinase Receptor
7%
Diagnostic Accuracy
7%
Mortality Rate
7%
Observational Study
7%
Adrenergic Receptor
7%
Somatomedin
7%
Varices
7%
Transcriptome
7%
Hepatitis B Virus
6%
Body Mass Index
5%
Beta Adrenergic Receptor Blocking
5%
Liver Dysfunction
5%
Hepatic Vein
5%
Pharmacology, Toxicology and Pharmaceutical Science
Liver Cirrhosis
42%
Chronic Hepatitis B
21%
Esophagus Varices
19%
Portal Hypertension
18%
Ascites
17%
Decompensated Liver Cirrhosis
16%
Placebo
16%
Rifaximin
14%
Carvedilol
14%
Inflammation
10%
Beta Adrenergic Receptor Blocking Agent
9%
Cohort Study
8%
Propranolol
8%
Anti-Inflammatory Drug
8%
Bleeding
8%
Bacterial DNA
8%
Adrenergic Receptor
7%
Chronic Liver Disease
7%
Somatomedin
7%
Mortality Rate
7%
Normal Human
7%
Ischemic Heart Disease
7%
Atorvastatin
7%
Observational Study
7%
Varicosis
7%
Hepatitis B Virus
6%
